Breast cancer risk depends on an accurate assessment of breast density due to lesion masking. Although governed by standardized guidelines, radiologist assessment of breast density is still highly variable. Automated breast density assessment tools leverage deep learning but are limited by model robustness and interpretability. We assessed the robustness of a feature selection methodology (RFE-SHAP) for classifying breast density grades using tissue-specific radiomic features extracted from raw central projections of digital breast tomosynthesis screenings ( <math xmlns="http://www.w3.org/1998/Math/MathML"> <mrow> <msub><mrow><mi>n</mi></mrow> <mrow><mi>I</mi></mrow> </msub> <mo>=</mo> <mn>651</mn></mrow> </math> , <math xmlns="http://www.w3.org/1998/Math/MathML"> <mrow> <msub><mrow><mi>n</mi></mrow> <mrow><mi>II</mi></mrow> </msub> <mo>=</mo> <mn>100</mn></mrow> </math> ). RFE-SHAP leverages traditional and explainable AI methods to identify highly predictive and influential features. A simple logistic regression (LR) classifier was used to assess classification performance, and unsupervised clustering was employed to investigate the intrinsic separability of density grade classes. LR classifiers yielded cross-validated areas under the receiver operating characteristic (AUCs) per density grade of [ <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mi>A</mi></mrow> </math> : <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mn>0.909</mn> <mo>±</mo> <mn>0.032</mn></mrow> </math> , <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mi>B</mi></mrow> </math> : <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mn>0.858</mn> <mo>±</mo> <mn>0.027</mn></mrow> </math> , <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mi>C</mi></mrow> </math> : <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mn>0.927</mn> <mo>±</mo> <mn>0.013</mn></mrow> </math> , <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mi>D</mi></mrow> </math> : <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mn>0.890</mn> <mo>±</mo> <mn>0.089</mn></mrow> </math> ] and an AUC of <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mn>0.936</mn> <mo>±</mo> <mn>0.016</mn></mrow> </math> for classifying patients as nondense or dense. In external validation, we observed per density grade AUCs of [ <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mi>A</mi></mrow> </math> : 0.880, <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mi>B</mi></mrow> </math> : 0.779, <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mi>C</mi></mrow> </math> : 0.878, <math xmlns="http://www.w3.org/1998/Math/MathML"><mrow><mi>D</mi></mrow> </math> : 0.673] and nondense/dense AUC of 0.823. Unsupervised clustering highlighted the ability of these features to characterize different density grades. Our RFE-SHAP feature selection methodology for classifying breast tissue density generalized well to validation datasets after accounting for natural class imbalance, and the identified radiomic features properly captured the progression of density grades. Our results potentiate future research into correlating selected radiomic features with clinical descriptors of breast tissue density.

Purpose To assess the agreement between routine-dose (RD) and lower-dose (LD) contrast-enhanced CT scans, with and without Digital Imaging and Communications in Medicine-based deep learning-based denoising (DLD), in evaluating small renal masses (SRMs) during active surveillance. Materials and Methods In this retrospective study, CT scans from patients undergoing active surveillance for an SRM were included. Using a validated simulation technique, LD CT images were generated from the RD images to simulate 75% (LD75) and 90% (LD90) radiation dose reductions. Two additional LD image sets, in which the DLD was applied (LD75-DLD and LD90-DLD), were generated. Between January 2023 and June 2024, nine radiologists from three institutions independently evaluated 350 CT scans across five datasets for tumor size, tumor nearness to the collecting system (TN), and tumor shape irregularity (TSI), and interobserver reproducibility and agreement were assessed using the 95% limits of agreement with the mean (LOAM) and Gwet AC2 coefficient, respectively. Subjective and quantitative image quality assessments were also performed. Results The study sample included 70 patients (mean age, 73.2 years ± 9.2 [SD]; 48 male, 22 female). LD75 CT was found to be in agreement with RD scans for assessing SRM diameter, with a LOAM of ±2.4 mm (95% CI: 2.3, 2.6) for LD75 compared with ±2.2 mm (95% CI: 2.1, 2.4) for RD. However, a 90% dose reduction compromised reproducibility (LOAM ±3.0 mm; 95% CI: 2.8, 3.2). LD90-DLD preserved measurement reproducibility (LOAM ±2.4 mm; 95% CI: 2.3, 2.6). Observer agreement was comparable between TN and TSI assessments across all image sets, with no statistically significant differences identified (all comparisons <i>P</i> ≥ .35 for TN and <i>P</i> ≥ .02 for TSI; Holm-corrected significance threshold, <i>P</i> = .013). Subjective and quantitative image quality assessments confirmed that DLD effectively restored image quality at reduced dose levels: LD75-DLD had the highest overall image quality, significantly lower noise, and improved contrast-to-noise ratio compared with RD (<i>P</i> < .001). Conclusion A 75% reduction in radiation dose is feasible for SRM assessment in active surveillance using CT with a conventional iterative reconstruction technique, whereas applying DLD allows submillisievert dose reduction. <b>Keywords:</b> CT, Urinary, Kidney, Radiation Safety, Observer Performance, Technology Assessment <i>Supplemental material is available for this article.</i> © RSNA, 2025 See also commentary by Muglia in this issue.

Clinical imaging trials play a crucial role in advancing medical innovation but are often costly, inefficient, and ethically constrained. Virtual Imaging Trials (VITs) present a solution by simulating clinical trial components in a controlled, risk-free environment. The Virtual Lung Screening Trial (VLST), an in silico study inspired by the National Lung Screening Trial (NLST), illustrates the potential of VITs to expedite clinical trials, minimize risks to participants, and promote optimal use of imaging technologies in healthcare. This study aimed to show that a virtual imaging trial platform could investigate some key elements of a major clinical trial, specifically the NLST, which compared Computed tomography (CT) and chest radiography (CXR) for lung cancer screening. With simulated cancerous lung nodules, a virtual patient cohort of 294 subjects was created using XCAT human models. Each virtual patient underwent both CT and CXR imaging, with deep learning models, the AI CT-Reader and AI CXR-Reader, acting as virtual readers to perform recall patients with suspicion of lung cancer. The primary outcome was the difference in diagnostic performance between CT and CXR, measured by the Area Under the Curve (AUC). The AI CT-Reader showed superior diagnostic accuracy, achieving an AUC of 0.92 (95 % CI: 0.90-0.95) compared to the AI CXR-Reader's AUC of 0.72 (95 % CI: 0.67-0.77). Furthermore, at the same 94 % CT sensitivity reported by the NLST, the VLST specificity of 73 % was similar to the NLST specificity of 73.4 %. This CT performance highlights the potential of VITs to replicate certain aspects of clinical trials effectively, paving the way toward a safe and efficient method for advancing imaging-based diagnostics.

To develop a deep subspace learning network that can function across different pulse sequences. A contrast-invariant component-by-component (CBC) network structure was developed and compared against previously reported spatiotemporal multicomponent (MC) structure for reconstructing MR Multitasking images. A total of 130, 167, and 16 subjects were imaged using T₁, T₁-T₂, and T₁-T₂- <math xmlns="http://www.w3.org/1998/Math/MathML"> <semantics> <mrow><msubsup><mi>T</mi> <mn>2</mn> <mo>*</mo></msubsup> </mrow> <annotation>$$ {\mathrm{T}}_2^{\ast } $$</annotation></semantics> </math> -fat fraction (FF) mapping sequences, respectively. We compared CBC and MC networks in matched-sequence experiments (same sequence for training and testing), then examined their cross-sequence performance and generalizability by unmatched-sequence experiments (different sequences for training and testing). A "universal" CBC network was also evaluated using mixed-sequence training (combining data from all three sequences). Evaluation metrics included image normalized root mean squared error and Bland-Altman analyses of end-diastolic maps, both versus iteratively reconstructed references. The proposed CBC showed significantly better normalized root mean squared error than MC in both matched-sequence and unmatched-sequence experiments (p < 0.001), fewer structural details in quantitative error maps, and tighter limits of agreement. CBC was more generalizable than MC (smaller performance loss; p = 0.006 in T₁ and p < 0.001 in T₁-T₂ from matched-sequence testing to unmatched-sequence testing) and additionally allowed training of a single universal network to reconstruct images from any of the three pulse sequences. The mixed-sequence CBC network performed similarly to matched-sequence CBC in T₁ (p = 0.178) and T₁-T₂ (p = 0121), where training data were plentiful, and performed better in T₁-T₂- <math xmlns="http://www.w3.org/1998/Math/MathML"> <semantics> <mrow><msubsup><mi>T</mi> <mn>2</mn> <mo>*</mo></msubsup> </mrow> <annotation>$$ {\mathrm{T}}_2^{\ast } $$</annotation></semantics> </math> -FF (p < 0.001) where training data were scarce. Contrast-invariant learning of spatial features rather than spatiotemporal features improves performance and generalizability, addresses data scarcity, and offers a pathway to universal supervised deep subspace learning.

Sparse-view Computed Tomography (CT) is an emerging protocol designed to reduce X-ray dose radiation in medical imaging. Reconstructions based on the traditional Filtered Back Projection algorithm suffer from severe artifacts due to sparse data. In contrast, Model-Based Iterative Reconstruction (MBIR) algorithms, though better at mitigating noise through regularization, are too computationally costly for clinical use. This paper introduces a novel technique, denoted as the Deep Guess acceleration scheme, using a trained neural network both to quicken the regularized MBIR and to enhance the reconstruction accuracy. We integrate state-of-the-art deep learning tools to initialize a clever starting guess for a proximal algorithm solving a non-convex model and thus computing a (mathematically) interpretable solution image in a few iterations. Experimental results on real and synthetic CT images demonstrate the Deep Guess effectiveness in (very) sparse tomographic protocols, where it overcomes its mere variational counterpart and many data-driven approaches at the state of the art. We also consider a ground truth-free implementation and test the robustness of the proposed framework to noise.

Functional magnetic resonance imaging (fMRI) has opened new frontiers in neuroscience by instrumentally driving our understanding of brain function and development. Despite its substantial successes, fMRI studies persistently encounter obstacles stemming from inherent, unavoidable physiological confounds. The adverse effects of these confounds are especially noticeable with higher magnetic fields, which have been gaining momentum in fMRI experiments. This review focuses on the four major physiological confounds impacting fMRI studies: low-frequency fluctuations in both breathing depth and rate, low-frequency fluctuations in the heart rate, thoracic movements, and cardiac pulsatility. Over the past three decades, numerous correction techniques have emerged to address these challenges. Correction methods have effectively enhanced the detection of task-activated voxels and minimized the occurrence of false positives and false negatives in functional connectivity studies. While confound correction methods have merit, they also have certain limitations. For instance, model-based approaches require externally recorded physiological data that is often unavailable in fMRI studies. Methods reliant on independent component analysis, on the other hand, need prior knowledge about the number of components. Machine learning techniques, although showing potential, are still in the early stages of development and require additional validation. This article reviews the mechanics of physiological confound correction methods, scrutinizes their performance and limitations, and discusses their impact on fMRI studies.

Artificial Intelligence models based on medical (imaging) data are increasingly developed. However, the imaging software on which the original data is generated is frequently updated. The impact of updated imaging software on the performance of AI models is unclear. We aimed to develop machine learning models using shear wave elastography (SWE) data to identify malignant breast lesions and to test the models' generalizability by validating them on external data generated by both the original updated software versions. We developed and validated different machine learning models (GLM, MARS, XGBoost, SVM) using multicenter, international SWE data (NCT02638935) using tenfold cross-validation. Findings were compared to the histopathologic evaluation of the biopsy specimen or 2-year follow-up. The outcome measure was the area under the curve (AUROC). We included 1288 cases in the development set using the original imaging software and 385 cases in the validation set using both, original and updated software. In the external validation set, the GLM and XGBoost models showed better performance with the updated software data compared to the original software data (AUROC 0.941 vs. 0.902, p < 0.001 and 0.934 vs. 0.872, p < 0.001). The MARS model showed worse performance with the updated software data (0.847 vs. 0.894, p = 0.045). SVM was not calibrated. In this multicenter study using SWE data, some machine learning models demonstrated great potential to bridge the gap between original software and updated software, whereas others exhibited weak generalizability.

In this work, we introduce a benchtop, turn-table photon-counting (PC) micro-CT scanner and highlight its application for dynamic small animal perfusion imaging.&#xD;Approach: Built on recently published hardware, the system now features a CdTe-based photon-counting detector (PCD). We validated its static spectral PC micro-CT imaging using conventional phantoms and assessed dynamic performance with a custom flow-configurable dual-compartment perfusion phantom. The phantom was scanned under varied flow conditions during injections of a low molecular weight iodinated contrast agent. In vivo mouse studies with identical injection settings demonstrated potential applications. A pretrained denoising CNN processed large multi-energy, temporal datasets (20 timepoints × 4 energies × 3 spatial dimensions), reconstructed via weighted filtered back projection. A separate CNN, trained on simulated data, performed gamma variate-based 2D perfusion mapping, evaluated qualitatively in phantom and in vivo tests.&#xD;Main Results: Full five-dimensional reconstructions were denoised using a CNN in ~3% of the time of iterative reconstruction, reducing noise in water at the highest energy threshold from 1206 HU to 86 HU. Decomposed iodine maps, which improved contrast to noise ratio from 16.4 (in the lowest energy CT images) to 29.4 (in the iodine maps), were used for perfusion analysis. The perfusion CNN outperformed pixelwise gamma variate fitting by ~33%, with a test set error of 0.04 vs. 0.06 in blood flow index (BFI) maps, and quantified linear BFI changes in the phantom with a coefficient of determination of 0.98.&#xD;Significance: This work underscores the PC micro-CT scanner's utility for high-throughput small animal perfusion imaging, leveraging spectral PC micro-CT and iodine decomposition. It provides a versatile platform for preclinical vascular research and advanced, time-resolved studies of disease models and therapeutic interventions.

The C-arm biplane imaging system, designed for cerebral angiography, detects pathologies like aneurysms using dual rotating detectors for high-precision, real-time vascular imaging. However, accuracy can be affected by source-detector trajectory deviations caused by gravitational artifacts and mechanical instabilities. This study addresses calibration challenges and suggests leveraging interventional devices with radio-opaque markers to optimize C-arm geometry. We propose an online calibration method using image-specific features derived from interventional devices like guidewires and catheters (In the remainder of this paper, the term"catheter" will refer to both catheter and guidewire). The process begins with gantry-recorded data, refined through iterative nonlinear optimization. A machine learning approach detects and segments elongated devices by identifying candidates via thresholding on a weighted sum of curvature, derivative, and high-frequency indicators. An ensemble classifier segments these regions, followed by post-processing to remove false positives, integrating vessel maps, manual correction and identification markers. An interpolation step filling gaps along the catheter. Among the optimized ensemble classifiers, the one trained on the first frames achieved the best performance, with a specificity of 99.43% and precision of 86.41%. The calibration method was evaluated on three clinical datasets and four phantom angiogram pairs, reducing the mean backprojection error from 4.11 ± 2.61 to 0.15 ± 0.01 mm. Additionally, 3D accuracy analysis showed an average root mean square error of 3.47% relative to the true marker distance. This study explores using interventional tools with radio-opaque markers for C-arm self-calibration. The proposed method significantly reduces 2D backprojection error and 3D RMSE, enabling accurate 3D vascular reconstruction.

As artificial intelligence (AI) becomes increasingly prevalent within interventional radiology (IR) research and clinical practice, steps must be taken to ensure the robustness of novel technological systems presented in peer-reviewed journals. This report introduces comprehensive standards and an evaluation checklist (iCARE) that covers the application of modern AI methods in IR-specific contexts. The iCARE checklist encompasses the full "code-to-clinic" pipeline of AI development, including dataset curation, pre-training, task-specific training, explainability, privacy protection, bias mitigation, reproducibility, and model deployment. The iCARE checklist aims to support the development of safe, generalizable technologies for enhancing IR workflows, the delivery of care, and patient outcomes.